AVADEL

interviewing with her right now. Can you give a little more feedback on her? Shes saying not a micro-manager at all?

She's not, until she see that your way is not her way!!! It's always only about the numbers and metrics and can go off on you at the spur of the moment. It's all about her and she never allows the spotlight to cast away from herself and has a "back stabbing competitiveness" to be on top. I'm sure you have noticed this if you've interviewed with her Fast talking rat poison.
 




Tired of waiting and will be calling to resend the acceptance of my contingent offer. Not liking what I'm hearing at all. Been there done that before and it's just not worth it.
 
















Well seeing as we can not compliantly have a name for the drug approved because it is too misleading, it’s going to be a while IF it ever happens. The FDA are just toying with us because they know how inept we are.
Seriously? We do not even have an approved brand name. Even if we are approved today, we are 3-6 months until launch.
 




You have to ask what are the chances their drug will get the Orphan and be fully approved by the FDA - and to explain to you the WHY they think so. Lots of smoke and mirrors, but nothing of substance. If it is not approved or the FDA asks for head-to-head studies vs. Jazz's Xyrem, you are looking at a 3 year delay; and you will be let go and no job.

Tell us how it goes.

If they get the orphan? They already got orphan designation. If there were any approval deficiencies they would have been given a CRL back in October. It's called a covid FDA delay. Jazz is nothing short of negligent for reformulating their twice nightly product to be low-sodium instead of buying Avadel's patent and creating a once nightly formulation.
 




















































What a joke this is.
We presented today some first grade questionnaire answers to a major conference. No efficacy data. No safety data.
Questionnaires? Who are these jokesters?